img

Global and United States Rituximab Injection Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Rituximab Injection Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and United States Rituximab Injection Market
This report focuses on global and United States Rituximab Injection market, also covers the segmentation data of other regions in regional level and county level.
The global Rituximab Injection revenue was US$ 1500 million in 2024 and is forecast to a readjusted size of US$ 5851 million by 2034 with a CAGR of 20.2% during the forecast period (2024-2034).
In United States the Rituximab Injection revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Rituximab Injection include Pfizer, Amgen, Roche, Celltrion, Innovent Biologics, Intas Pharmaceuticals, Shanghai Henlius Biotech, Fosun-Pharmaceutical and Lexicare Pharma, etc. The global five biggest players hold a share of % in 2024.
Global Rituximab Injection Scope and Market Size
Rituximab Injection market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Rituximab Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Rituximab Injection market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Pfizer
Amgen
Roche
Celltrion
Innovent Biologics
Intas Pharmaceuticals
Shanghai Henlius Biotech
Fosun-Pharmaceutical
Lexicare Pharma
Healthiza Lifescience
Kavya Pharma
Cadila Pharmaceuticals
Dr Reddy’s Laboratories
Hetero Group
Probiomed
TRPharma
Zenotech Laboratories
Segment by Type
Original Drugs
Generic Drugs

Segment by Application


Hospitals
Clinics
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Rituximab Injection definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Rituximab Injection companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Rituximab Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rituximab Injection sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Rituximab Injection Product Introduction
1.2 Global Rituximab Injection Outlook 2018 VS 2024 VS 2034
1.2.1 Global Rituximab Injection Sales in US$ Million for the Year 2018-2034
1.2.2 Global Rituximab Injection Sales in Volume for the Year 2018-2034
1.3 United States Rituximab Injection Outlook 2018 VS 2024 VS 2034
1.3.1 United States Rituximab Injection Sales in US$ Million for the Year 2018-2034
1.3.2 United States Rituximab Injection Sales in Volume for the Year 2018-2034
1.4 Rituximab Injection Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Rituximab Injection in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Rituximab Injection Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Rituximab Injection Market Dynamics
1.5.1 Rituximab Injection Industry Trends
1.5.2 Rituximab Injection Market Drivers
1.5.3 Rituximab Injection Market Challenges
1.5.4 Rituximab Injection Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Rituximab Injection by Type
2.1 Rituximab Injection Market Segment by Type
2.1.1 Original Drugs
2.1.2 Generic Drugs
2.2 Global Rituximab Injection Market Size by Type
2.2.1 Global Rituximab Injection Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Rituximab Injection Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Rituximab Injection Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Rituximab Injection Market Size by Type
2.3.1 United States Rituximab Injection Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Rituximab Injection Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Rituximab Injection Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Rituximab Injection by Application
3.1 Rituximab Injection Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Rituximab Injection Market Size by Application
3.2.1 Global Rituximab Injection Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Rituximab Injection Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Rituximab Injection Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Rituximab Injection Market Size by Application
3.3.1 United States Rituximab Injection Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Rituximab Injection Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Rituximab Injection Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Rituximab Injection Competitor Landscape by Company
4.1 Global Rituximab Injection Market Size by Company
4.1.1 Global Key Manufacturers of Rituximab Injection, Ranked by Revenue (2024)
4.1.2 Global Rituximab Injection Revenue by Manufacturer (2018-2023)
4.1.3 Global Rituximab Injection Sales by Manufacturer (2018-2023)
4.1.4 Global Rituximab Injection Price by Manufacturer (2018-2023)
4.2 Global Rituximab Injection Concentration Ratio (CR)
4.2.1 Rituximab Injection Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rituximab Injection in 2024
4.2.3 Global Rituximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Rituximab Injection, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Rituximab Injection, Product Offered and Application
4.5 Global Key Manufacturers of Rituximab Injection, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Rituximab Injection Market Size by Company
4.7.1 Key Players of Rituximab Injection in United States, Ranked by Revenue (2024)
4.7.2 United States Rituximab Injection Revenue by Players (2018-2023)
4.7.3 United States Rituximab Injection Sales by Players (2018-2023)
5 Global Rituximab Injection Market Size by Region
5.1 Global Rituximab Injection Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Rituximab Injection Market Size in Volume by Region (2018-2034)
5.2.1 Global Rituximab Injection Sales in Volume by Region: 2018-2023
5.2.2 Global Rituximab Injection Sales in Volume Forecast by Region (2024-2034)
5.3 Global Rituximab Injection Market Size in Value by Region (2018-2034)
5.3.1 Global Rituximab Injection Sales in Value by Region: 2018-2023
5.3.2 Global Rituximab Injection Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Rituximab Injection Market Size YoY Growth 2018-2034
6.2 Americas Rituximab Injection Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Rituximab Injection Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Rituximab Injection Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Rituximab Injection Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Rituximab Injection Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Rituximab Injection Market Size YoY Growth 2018-2034
7.2 EMEA Rituximab Injection Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Rituximab Injection Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Rituximab Injection Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Rituximab Injection Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Rituximab Injection Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Rituximab Injection Market Size YoY Growth 2018-2034
8.2 China Rituximab Injection Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Rituximab Injection Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Rituximab Injection Market Size YoY Growth 2018-2034
9.2 APAC Rituximab Injection Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Rituximab Injection Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Rituximab Injection Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Rituximab Injection Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Rituximab Injection Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Description and Business Overview
10.1.3 Pfizer Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Rituximab Injection Products Offered
10.1.5 Pfizer Recent Development
10.2 Amgen
10.2.1 Amgen Company Information
10.2.2 Amgen Description and Business Overview
10.2.3 Amgen Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Amgen Rituximab Injection Products Offered
10.2.5 Amgen Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Description and Business Overview
10.3.3 Roche Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Roche Rituximab Injection Products Offered
10.3.5 Roche Recent Development
10.4 Celltrion
10.4.1 Celltrion Company Information
10.4.2 Celltrion Description and Business Overview
10.4.3 Celltrion Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Celltrion Rituximab Injection Products Offered
10.4.5 Celltrion Recent Development
10.5 Innovent Biologics
10.5.1 Innovent Biologics Company Information
10.5.2 Innovent Biologics Description and Business Overview
10.5.3 Innovent Biologics Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Innovent Biologics Rituximab Injection Products Offered
10.5.5 Innovent Biologics Recent Development
10.6 Intas Pharmaceuticals
10.6.1 Intas Pharmaceuticals Company Information
10.6.2 Intas Pharmaceuticals Description and Business Overview
10.6.3 Intas Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Intas Pharmaceuticals Rituximab Injection Products Offered
10.6.5 Intas Pharmaceuticals Recent Development
10.7 Shanghai Henlius Biotech
10.7.1 Shanghai Henlius Biotech Company Information
10.7.2 Shanghai Henlius Biotech Description and Business Overview
10.7.3 Shanghai Henlius Biotech Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Shanghai Henlius Biotech Rituximab Injection Products Offered
10.7.5 Shanghai Henlius Biotech Recent Development
10.8 Fosun-Pharmaceutical
10.8.1 Fosun-Pharmaceutical Company Information
10.8.2 Fosun-Pharmaceutical Description and Business Overview
10.8.3 Fosun-Pharmaceutical Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Fosun-Pharmaceutical Rituximab Injection Products Offered
10.8.5 Fosun-Pharmaceutical Recent Development
10.9 Lexicare Pharma
10.9.1 Lexicare Pharma Company Information
10.9.2 Lexicare Pharma Description and Business Overview
10.9.3 Lexicare Pharma Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Lexicare Pharma Rituximab Injection Products Offered
10.9.5 Lexicare Pharma Recent Development
10.10 Healthiza Lifescience
10.10.1 Healthiza Lifescience Company Information
10.10.2 Healthiza Lifescience Description and Business Overview
10.10.3 Healthiza Lifescience Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Healthiza Lifescience Rituximab Injection Products Offered
10.10.5 Healthiza Lifescience Recent Development
10.11 Kavya Pharma
10.11.1 Kavya Pharma Company Information
10.11.2 Kavya Pharma Description and Business Overview
10.11.3 Kavya Pharma Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Kavya Pharma Rituximab Injection Products Offered
10.11.5 Kavya Pharma Recent Development
10.12 Cadila Pharmaceuticals
10.12.1 Cadila Pharmaceuticals Company Information
10.12.2 Cadila Pharmaceuticals Description and Business Overview
10.12.3 Cadila Pharmaceuticals Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Cadila Pharmaceuticals Rituximab Injection Products Offered
10.12.5 Cadila Pharmaceuticals Recent Development
10.13 Dr Reddy’s Laboratories
10.13.1 Dr Reddy’s Laboratories Company Information
10.13.2 Dr Reddy’s Laboratories Description and Business Overview
10.13.3 Dr Reddy’s Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Dr Reddy’s Laboratories Rituximab Injection Products Offered
10.13.5 Dr Reddy’s Laboratories Recent Development
10.14 Hetero Group
10.14.1 Hetero Group Company Information
10.14.2 Hetero Group Description and Business Overview
10.14.3 Hetero Group Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Hetero Group Rituximab Injection Products Offered
10.14.5 Hetero Group Recent Development
10.15 Probiomed
10.15.1 Probiomed Company Information
10.15.2 Probiomed Description and Business Overview
10.15.3 Probiomed Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Probiomed Rituximab Injection Products Offered
10.15.5 Probiomed Recent Development
10.16 TRPharma
10.16.1 TRPharma Company Information
10.16.2 TRPharma Description and Business Overview
10.16.3 TRPharma Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.16.4 TRPharma Rituximab Injection Products Offered
10.16.5 TRPharma Recent Development
10.17 Zenotech Laboratories
10.17.1 Zenotech Laboratories Company Information
10.17.2 Zenotech Laboratories Description and Business Overview
10.17.3 Zenotech Laboratories Rituximab Injection Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Zenotech Laboratories Rituximab Injection Products Offered
10.17.5 Zenotech Laboratories Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Rituximab Injection Industry Chain Analysis
11.2 Rituximab Injection Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Rituximab Injection Production Mode & Process
11.4 Rituximab Injection Sales and Marketing
11.4.1 Rituximab Injection Sales Channels
11.4.2 Rituximab Injection Distributors
11.5 Rituximab Injection Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Rituximab Injection CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Rituximab Injection Market Trends
Table 3. Rituximab Injection Market Drivers
Table 4. Rituximab Injection Market Challenges
Table 5. Rituximab Injection Market Restraints
Table 6. Global Rituximab Injection Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Rituximab Injection Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Rituximab Injection Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Rituximab Injection Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Rituximab Injection, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Rituximab Injection Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Rituximab Injection Revenue Share by Manufacturer, 2018-2023
Table 13. Global Rituximab Injection Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Rituximab Injection Sales Share by Manufacturer, 2018-2023
Table 15. Global Rituximab Injection Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Rituximab Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Rituximab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rituximab Injection as of 2024)
Table 18. Global Key Manufacturers of Rituximab Injection, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Rituximab Injection, Product Offered and Application
Table 20. Global Key Manufacturers of Rituximab Injection, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Rituximab Injection in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Rituximab Injection Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Rituximab Injection Revenue Share by Players, (2018-2023)
Table 25. United States Rituximab Injection Sales by Players, (K Units), (2018-2023)
Table 26. United States Rituximab Injection Sales Share by Players, (2018-2023)
Table 27. Global Rituximab Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Rituximab Injection Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Rituximab Injection Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Rituximab Injection Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Rituximab Injection Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Rituximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Rituximab Injection Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Rituximab Injection Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Rituximab Injection Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Rituximab Injection Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Rituximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Rituximab Injection Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Rituximab Injection Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Rituximab Injection Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Rituximab Injection Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Rituximab Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Rituximab Injection Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Rituximab Injection Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Rituximab Injection Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Rituximab Injection Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Pfizer Company Information
Table 48. Pfizer Description and Business Overview
Table 49. Pfizer Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Pfizer Rituximab Injection Product
Table 51. Pfizer Recent Development
Table 52. Amgen Company Information
Table 53. Amgen Description and Business Overview
Table 54. Amgen Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Amgen Rituximab Injection Product
Table 56. Amgen Recent Development
Table 57. Roche Company Information
Table 58. Roche Description and Business Overview
Table 59. Roche Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Roche Rituximab Injection Product
Table 61. Roche Recent Development
Table 62. Celltrion Company Information
Table 63. Celltrion Description and Business Overview
Table 64. Celltrion Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Celltrion Rituximab Injection Product
Table 66. Celltrion Recent Development
Table 67. Innovent Biologics Company Information
Table 68. Innovent Biologics Description and Business Overview
Table 69. Innovent Biologics Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Innovent Biologics Rituximab Injection Product
Table 71. Innovent Biologics Recent Development
Table 72. Intas Pharmaceuticals Company Information
Table 73. Intas Pharmaceuticals Description and Business Overview
Table 74. Intas Pharmaceuticals Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Intas Pharmaceuticals Rituximab Injection Product
Table 76. Intas Pharmaceuticals Recent Development
Table 77. Shanghai Henlius Biotech Company Information
Table 78. Shanghai Henlius Biotech Description and Business Overview
Table 79. Shanghai Henlius Biotech Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Shanghai Henlius Biotech Rituximab Injection Product
Table 81. Shanghai Henlius Biotech Recent Development
Table 82. Fosun-Pharmaceutical Company Information
Table 83. Fosun-Pharmaceutical Description and Business Overview
Table 84. Fosun-Pharmaceutical Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Fosun-Pharmaceutical Rituximab Injection Product
Table 86. Fosun-Pharmaceutical Recent Development
Table 87. Lexicare Pharma Company Information
Table 88. Lexicare Pharma Description and Business Overview
Table 89. Lexicare Pharma Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Lexicare Pharma Rituximab Injection Product
Table 91. Lexicare Pharma Recent Development
Table 92. Healthiza Lifescience Company Information
Table 93. Healthiza Lifescience Description and Business Overview
Table 94. Healthiza Lifescience Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Healthiza Lifescience Rituximab Injection Product
Table 96. Healthiza Lifescience Recent Development
Table 97. Kavya Pharma Company Information
Table 98. Kavya Pharma Description and Business Overview
Table 99. Kavya Pharma Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Kavya Pharma Rituximab Injection Product
Table 101. Kavya Pharma Recent Development
Table 102. Cadila Pharmaceuticals Company Information
Table 103. Cadila Pharmaceuticals Description and Business Overview
Table 104. Cadila Pharmaceuticals Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Cadila Pharmaceuticals Rituximab Injection Product
Table 106. Cadila Pharmaceuticals Recent Development
Table 107. Dr Reddy’s Laboratories Company Information
Table 108. Dr Reddy’s Laboratories Description and Business Overview
Table 109. Dr Reddy’s Laboratories Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Dr Reddy’s Laboratories Rituximab Injection Product
Table 111. Dr Reddy’s Laboratories Recent Development
Table 112. Hetero Group Company Information
Table 113. Hetero Group Description and Business Overview
Table 114. Hetero Group Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Hetero Group Rituximab Injection Product
Table 116. Hetero Group Recent Development
Table 117. Probiomed Company Information
Table 118. Probiomed Description and Business Overview
Table 119. Probiomed Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Probiomed Rituximab Injection Product
Table 121. Probiomed Recent Development
Table 122. TRPharma Company Information
Table 123. TRPharma Description and Business Overview
Table 124. TRPharma Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. TRPharma Rituximab Injection Product
Table 126. TRPharma Recent Development
Table 127. Zenotech Laboratories Company Information
Table 128. Zenotech Laboratories Description and Business Overview
Table 129. Zenotech Laboratories Rituximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Zenotech Laboratories Rituximab Injection Product
Table 131. Zenotech Laboratories Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Rituximab Injection Customers List
Table 135. Rituximab Injection Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Rituximab Injection Product Picture
Figure 2. Global Rituximab Injection Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Rituximab Injection Market Size 2018-2034 (US$ Million)
Figure 4. Global Rituximab Injection Sales 2018-2034 (K Units)
Figure 5. United States Rituximab Injection Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Rituximab Injection Market Size 2018-2034 (US$ Million)
Figure 7. United States Rituximab Injection Sales 2018-2034 (K Units)
Figure 8. United States Rituximab Injection Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Rituximab Injection Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Rituximab Injection Report Years Considered
Figure 11. Product Picture of Original Drugs
Figure 12. Product Picture of Generic Drugs
Figure 13. Global Rituximab Injection Market Share by Type in 2024 & 2034
Figure 14. Global Rituximab Injection Sales in Value by Type (2018-2034) & (US$ Million)
Figure 15. Global Rituximab Injection Sales Market Share in Value by Type (2018-2034)
Figure 16. Global Rituximab Injection Sales by Type (2018-2034) & (K Units)
Figure 17. Global Rituximab Injection Sales Market Share in Volume by Type (2018-2034)
Figure 18. Global Rituximab Injection Price by Type (2018-2034) & (US$/Unit)
Figure 19. United States Rituximab Injection Market Share by Type in 2024 & 2034
Figure 20. United States Rituximab Injection Sales in Value by Type (2018-2034) & (US$ Million)
Figure 21. United States Rituximab Injection Sales Market Share in Value by Type (2018-2034)
Figure 22. United States Rituximab Injection Sales by Type (2018-2034) & (K Units)
Figure 23. United States Rituximab Injection Sales Market Share in Volume by Type (2018-2034)
Figure 24. United States Rituximab Injection Price by Type (2018-2034) & (US$/Unit)
Figure 25. Product Picture of Hospitals
Figure 26. Product Picture of Clinics
Figure 27. Product Picture of Others
Figure 28. Global Rituximab Injection Market Share by Application in 2024 & 2034
Figure 29. Global Rituximab Injection Sales in Value by Application (2018-2034) & (US$ Million)
Figure 30. Global Rituximab Injection Sales Market Share in Value by Application (2018-2034)
Figure 31. Global Rituximab Injection Sales by Application (2018-2034) & (K Units)
Figure 32. Global Rituximab Injection Sales Market Share in Volume by Application (2018-2034)
Figure 33. Global Rituximab Injection Price by Application (2018-2034) & (US$/Unit)
Figure 34. United States Rituximab Injection Market Share by Application in 2024 & 2034
Figure 35. United States Rituximab Injection Sales in Value by Application (2018-2034) & (US$ Million)
Figure 36. United States Rituximab Injection Sales Market Share in Value by Application (2018-2034)
Figure 37. United States Rituximab Injection Sales by Application (2018-2034) & (K Units)
Figure 38. United States Rituximab Injection Sales Market Share in Volume by Application (2018-2034)
Figure 39. United States Rituximab Injection Price by Application (2018-2034) & (US$/Unit)
Figure 40. Americas Rituximab Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 41. Americas Rituximab Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 42. Americas Rituximab Injection Sales by Type (2018-2034) & (K Units)
Figure 43. Americas Rituximab Injection Sales Market Share in Volume by Type (2018-2034)
Figure 44. Americas Rituximab Injection Sales by Application (2018-2034) & (K Units)
Figure 45. Americas Rituximab Injection Sales Market Share in Volume by Application (2018-2034)
Figure 46. United States Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 47. Canada Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Mexico Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. EMEA Rituximab Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 51. EMEA Rituximab Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 52. EMEA Rituximab Injection Sales by Type (2018-2034) & (K Units)
Figure 53. EMEA Rituximab Injection Sales Market Share in Volume by Type (2018-2034)
Figure 54. EMEA Rituximab Injection Sales by Application (2018-2034) & (K Units)
Figure 55. EMEA Rituximab Injection Sales Market Share in Volume by Application (2018-2034)
Figure 56. Europe Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 57. Middle East Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Africa Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. China Rituximab Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 60. China Rituximab Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 61. China Rituximab Injection Sales by Type (2018-2034) & (K Units)
Figure 62. China Rituximab Injection Sales Market Share in Volume by Type (2018-2034)
Figure 63. China Rituximab Injection Sales by Application (2018-2034) & (K Units)
Figure 64. China Rituximab Injection Sales Market Share in Volume by Application (2018-2034)
Figure 65. APAC Rituximab Injection Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 66. APAC Rituximab Injection Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 67. APAC Rituximab Injection Sales by Type (2018-2034) & (K Units)
Figure 68. APAC Rituximab Injection Sales Market Share in Volume by Type (2018-2034)
Figure 69. APAC Rituximab Injection Sales by Application (2018-2034) & (K Units)
Figure 70. APAC Rituximab Injection Sales Market Share in Volume by Application (2018-2034)
Figure 71. Japan Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 72. South Korea Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. China Taiwan Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. Southeast Asia Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. India Rituximab Injection Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. Rituximab Injection Value Chain
Figure 77. Rituximab Injection Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed